LEXICON PHARMACEUTICALS, INC. - COM NEW (LXRX)

Historical Portfolio Holders from Q2 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
278M
Holdings value Q2 2024
$468M
Value change Q2 2024
+$176M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
121
Number of buys Q2 2024
11
Number of sells Q2 2024
-3
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.96M $4.58M +$401K $1.57 24
2024 Q2 278M $468M +$176M $1.68 122
2024 Q1 172M $412M -$25M $2.40 115
2023 Q4 183M $280M -$6.76M $1.53 103
2023 Q3 189M $206M -$5.68M $1.09 109
2023 Q2 191M $438M +$105M $2.29 121
2023 Q1 146M $354M -$3M $2.43 103
2022 Q4 147M $280M -$3.98M $1.91 100
2022 Q3 149M $357M +$72.6M $2.40 97
2022 Q2 119M $221M -$2.43M $1.86 82
2022 Q1 120M $251M -$5.57M $2.09 102
2021 Q4 122M $479M -$1.47M $3.94 109
2021 Q3 121M $583M +$17.3M $4.81 96
2021 Q2 118M $540M +$2.12M $4.59 106
2021 Q1 121M $712M +$117K $5.87 106
2020 Q4 122M $417M +$65.7M $3.42 102
2020 Q3 104M $150M -$5.09M $1.44 87
2020 Q2 107M $214M +$4.8M $1.99 101
2020 Q1 105M $204M -$17.2M $1.95 108
2019 Q4 107M $445M +$20.4M $4.15 111
2019 Q3 102M $308M -$30M $3.01 96
2019 Q2 105M $662M +$7.04M $6.29 107
2019 Q1 104M $580M -$6.64M $5.56 115
2018 Q4 105M $700M -$17.1M $6.64 120
2018 Q3 107M $1.15B -$30M $10.67 118
2018 Q2 104M $1.25B -$372K $12.00 116
2018 Q1 110M $940M -$14.1M $8.57 119
2017 Q4 111M $1.1B -$44.2M $9.88 125
2017 Q3 110M $1.36B -$5.81M $12.29 130
2017 Q2 110M $1.82B +$18.3M $16.45 127
2017 Q1 110M $1.58B +$120M $14.34 130
2016 Q4 106M $1.47B -$2.53M $13.83 140
2016 Q3 106M $1.92B -$587K $18.07 137
2016 Q2 111M $1.59B +$912K $14.35 132
2016 Q1 111M $1.32B +$13.9M $11.95 125
2015 Q4 110M $1.46B +$55.1M $13.31 115
2015 Q3 106M $1.14B +$98.4M $10.74 101
2015 Q2 96.8M $779M +$779M $8.05 86